Key Insights

Highlights

Success Rate

90% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

4.5%

1 terminated out of 22 trials

Success Rate

90.0%

+3.5% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

22%

2 of 9 completed with results

Key Signals

2 with results90% success

Data Visualizations

Phase Distribution

14Total
Not Applicable (13)
P 2 (1)

Trial Status

Completed9
Unknown5
Recruiting3
Not Yet Recruiting2
Terminated1
Enrolling By Invitation1

Trial Success Rate

90.0%

Benchmark: 86.5%

Based on 9 completed trials

Clinical Trials (22)

Showing 20 of 20 trials
NCT03364114Not ApplicableTerminatedPrimary

Endorotor Resection In Refractory Barrett's Dysplasia Patients

NCT07343869Not Yet Recruiting

Multicenter Prospective Cohort on Esophageal Endoscopic Submucosal Dissection

NCT06071845Not ApplicableRecruiting

Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal Samples

NCT05753748Not ApplicableRecruitingPrimary

Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia

NCT04561791Not ApplicableEnrolling By Invitation

Evaluation of Tethered Capsule Endomicroscopy as a Screening Tool for Barrett's Esophagus in the Primary Care Setting

NCT02994693Active Not Recruiting

Natural History of Barrett's Esophagus Using Tethered Capsule Endomicroscopy

NCT06030180Not ApplicableCompleted

CLUE: CLinical Utility Study of EsoGuard

NCT05530343Not ApplicableRecruiting

Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance

NCT06381583Completed

A Liquid Biopsy for High-risk Pre-cancer Screening of Esophageal Adenocarcinoma

NCT04316975Not ApplicableCompletedPrimary

Utility Of Mutational Load As A Predictor For Endoscopic Treatment Response In Barrett's Esophagus

NCT05983419Not ApplicableUnknownPrimary

Complete Resection of Barrett's Esophagus Harboring Neoplasia With Endoscopic Submucosal Dissection.

NCT05965999Unknown

Lucid Registry Study

NCT04001478Unknown

Non-invasive Testing for Early oEesophageal Cancer and Dysplasia

NCT03193216Phase 2CompletedPrimary

The Impact of Adjuvant Liquid Alginate on Endoscopic Ablation Therapy of Complicated Barrett's Esophagus

NCT04295811Not ApplicableUnknown

Efficacy of EsoGuard Assay on Esophageal Surface Cells Collected With EsoCheck vs EGD for the Diagnosis of BE or EAC

NCT04293458Not ApplicableCompleted

Efficacy of EsoGuard on Samples Collected Using EsoCheck Versus EGD for the Diagnosis of BE

NCT03077594CompletedPrimary

Characterization of the Neo-squamous Epithelial Barrier

NCT03814824Not ApplicableCompleted

Volumetric Laser Endomicroscopy With Intelligent Real-time Image Segmentation (IRIS)

NCT05276791Not ApplicableNot Yet RecruitingPrimary

EMR Versus ESD for Barrett's Neoplasia

NCT04843397Unknown

Diagnostic Performance Indicators in Upper GI Endoscopy:PROSPERO Study

Scroll to load more

Research Network

Activity Timeline